{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6447cb7391dbd3001135bccf/6766c40d25a0b820a28ebca6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Sensemaker: Denmark's gold rush town","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6447cb7391dbd3001135bccf/1734788038285-e7eb7c86-595b-40bd-a7af-61554d2abd0d.jpeg?height=200","description":"<p>2024<em> </em>was weight-loss injections such as Ozempic and WeGovy went global.&nbsp;What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?</p><p><br></p><p>Writer: Claudia Williams</p><p>Producer: Claudia Williams</p><p>Photography: Joe Mee</p><p>Executive producer: Rebecca Moore</p>","author_name":"The Observer"}